Anterior Cruciate Ligament Tear, Knee Sprain (Mild), Knee Sprain (Moderate)
Conditions
Brief summary
Decathlon has developed kneeMID500-STRONG700 products which are two medical devices designed to be used for sport resumption after mild (kneeMID500) or moderate (KneeSTRONG100) knee sprain or after an Anterior Cruciate Ligament surgery. The difference between these devices is based on the strength of compression and the knee maintain. The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon kneeMID500-STRONG700 products to demonstrate safety and performance of these devices in a real-world setting.
Interventions
DEVICEkneeMID500-STRONG700
At least 30 patients (15 patients in the orthosis group and 15 patients in the control group) per device type (2 device types: Knee MID 500 and Knee STRONG 700) totalling 60 patients will be included. Patients included in the orthosis group will use the device during sports sessions while patients included in the control group will not use a knee support device.
Sponsors
EFOR, France
Decathlon SE
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Subject is aged ≥18 years old * Subject has a recent mild (grade I) OR moderate (grade II) knee sprain OR an ACL surgery * The current condition of his/her knee allows the subject to resume usual physical activity * Subject has been informed and is willing to sign an informed consent form * Subject is willing to comply with protocol requirements and return to the study center for all clinical evaluations and required follow-up (18 weeks) * Subject is affiliated to the French social security regime Non-inclusion Criteria: * Subject has conditions that may interfere with his/her ability to understand protocol requirements, participate in scheduled visits, or provide his/her informed consent * Subject has worn a support (knee brace or articulated orthosis) since his/her recent injury * Subject has resumed regular physical activity since his/her recent injury * Subject has any medical condition that could impact the study at investigator's discretion * Subject has a known hypersensitivity or allergy to the components of the device (polyamide, elastane, elastodiene) * Adult subject to a legal protection measure
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Functional score | At baseline and 18 weeks of follow-up | Comparison of the functional result (Lysholm Score: 0-100 points ; Tegner Activity Scale: 11-level gradient) between the baseline and last follow-up visit in each group (orthosis vs control), for each device model |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Confidence level | At baseline and 18 weeks of follow-up | Gap in the confidence level (patient rated outcome with 6 questions, ranging from 0 to 100) related to physical activity, between the baseline and last follow-up visit in each group (orthosis vs control), for each device model |
| Knee instability | At 6 weeks, 12 weeks and 18 weeks of follow-up | Comparison of knee instability, assessed through a numerical rating scale (NRS, ranging from 0 to 10), between the groups (orthosis vs control), for each device model |
| Knee pain | At 6 weeks, 12 weeks and 18 weeks of follow-up | Comparison of knee pain, assessed through NRS (ranging from 0 to 10), between the groups (orthosis vs control), for each device model |
| Safety (adverse events) | 18 weeks of follow-up | Comparison of adverse events rates between the groups (orthosis vs control), for each device model |
Countries
France
Contacts
Primary ContactJean HEE
Outcome results
None listed